Clinical Edge

Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions

Primary immunodeficiency disease patients have high risk of invasive fungal disease

Key clinical point: PID patients are at high risk of developing fungal infections with high mortality.

Major finding: The mortality rate among patients was 10/28 (35.7%).

Study details: A total of 28 PID patients diagnosed with fungal infections were assessed.

Disclosures: There was no outside funding and the authors reported having no conflicts.

Citation:

Elaziz DA et al. Clinical Immunology. 2020; doi.org/10.1016/j.clim.2020.108553.